Doctors at the UVM Medical Center are urging parents and guardians to get Respiratory syncytial virus (RSV) immunizations for their infants and newborns. A new RSV prevention medication, called ...

Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Dr. Patrick Hemmons travelled to Seattle to get an RSV shot for his daughter. He says he hopes to see nirsevimab become more ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led to a tenfold increase in the number of infants in that group that were ...

Sanofi and AstraZeneca are closing in on EU approval of nirsevimab, their long-acting antibody for the protection of newborns and infants from respiratory syncytial virus (RSV) infections.

The price you pay for Beyfortus may depend on factors such as your child’s dosage and whether you have health insurance. Financial assistance may be available to help you with the cost of Beyfortus.

Three-quarters of infants were exposed to the maternal RSV vaccine or nirsevimab during their first RSV season. Younger mothers and Black mothers were less likely to receive the maternal vaccine.

It is the first approval for Beyfortus (nirsevimab) by any regulatory authority. AZ's Synagis (palivizumab) is currently the only approved drug in Europe to provide passive prophylaxis against RSV ...

The study involving 8,000 babies in Europe showed the drug nirsevimab lowered RSV-related hospitalisations by 83%, drug firm Sanofi said. University Hospital Southampton (UHS), which took part in ...

When Dr. Patrick Hemmons's daughter Saoirse was born pre-term late last year, he wanted to protect her ahead of the coming respiratory illness season. Hemmons, who is a family physician practising ...